ÂÜÀòÂÒÂ×

Giles Dudley is the Chief Business Officer at Stimuliver, a cell therapy company, and AdaptVac, a joint-venture focusing on vaccine development. Giles also serves as a Spark Program Member and Advisor at Spark Denmark, a Startup Mentor at NOME, and an Advisor at Innovate UK. Previously, Giles was the Director of Business Development at BioInnovation Institute and holds various board positions in companies focusing on CRISPR technology, therapeutics, male infertility treatment, and psychedelic drug development. Giles holds a PhD in Virology from the University of Glasgow and a B.Sc. in Molecular Biology and Biochemistry from the University of the West of England.